Amorphous solid dispersion (ASD) is one of the most effective approaches for delivering
poorly soluble drugs. In ASDs, polymeric materials serve as the carriers in which the drugs …

Polymeric amorphous solid dispersion (ASD) is a popular approach for enhancing the
solubility of poorly water-soluble drugs. However, achieving both physical stability and …

This study aims to investigate the potential use of polymer inclusion in the phospholipid-
based solid dispersion approach for augmenting the biopharmaceutical performance of …

The incorporation of counterions into amorphous solid dispersions (ASDs) has been proven
to be effective for improving the dissolution rates of ionizable drugs in ASDs. In this work, the …

Amorphous solid dispersions (ASDs) are an enabling formulation approach used to
enhance bioavailability of poorly water-soluble molecules in oral drug products. Drug-rich …

Amorphous solid dispersions (ASDs) represent an important approach for enhancing oral
bioavailability for poorly water soluble compounds; however, assuring that these ASDs do …

Crystal agglomeration is a common phenomenon for most chemicals and pharmaceuticals.
The formation of agglomerates usually lowers product purity and generates a broad particle …

Celecoxib (CXB) is a nonsteroidal anti-inflammatory drug (NSAID). However, the application
of CXB has been compromised by its poor aqueous solubility and low oral bioavailability …